# Ondansetron and Gabapentin in Preventing Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy

> **NCT05620641** · PHASE3 · COMPLETED · sponsor: **Tanta University** · enrollment: 100 (actual)

## Conditions studied

- Post Operative Nausea and Vomiting
- Sleeve Gastrectomy
- Morbid Obesity

## Interventions

- **DRUG:** Ondansetron 8mg
- **DRUG:** Gabapentin

## Key facts

- **NCT ID:** NCT05620641
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-01
- **Primary completion:** 2025-02-28
- **Final completion:** 2025-04-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2025-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05620641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05620641, "Ondansetron and Gabapentin in Preventing Postoperative Nausea and Vomiting After Laparoscopic Sleeve Gastrectomy". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05620641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*